BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19801928)

  • 1. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.
    Maher SG; Gillham CM; Duggan SP; Smyth PC; Miller N; Muldoon C; O'Byrne KJ; Sheils OM; Hollywood D; Reynolds JV
    Ann Surg; 2009 Nov; 250(5):729-37. PubMed ID: 19801928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C; Greenawalt DM; Kowalczyk A; Ciavarella ML; Raskutti G; Murray WK; Phillips WA; Thomas RJ
    Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray-based response prediction in esophageal adenocarcinoma.
    Schauer M; Janssen KP; Rimkus C; Raggi M; Feith M; Friess H; Theisen J
    Clin Cancer Res; 2010 Jan; 16(1):330-7. PubMed ID: 20028767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
    Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
    Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of response to preoperative chemoradiation in esophageal cancers.
    Luthra R; Luthra MG; Izzo J; Wu TT; Lopez-Alvarez E; Malhotra U; Choi IS; Zhang L; Ajani JA
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S2-5. PubMed ID: 17178277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.
    Luthra R; Wu TT; Luthra MG; Izzo J; Lopez-Alvarez E; Zhang L; Bailey J; Lee JH; Bresalier R; Rashid A; Swisher SG; Ajani JA
    J Clin Oncol; 2006 Jan; 24(2):259-67. PubMed ID: 16344314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation.
    Maher SG; McDowell DT; Collins BC; Muldoon C; Gallagher WM; Reynolds JV
    Ann Surg; 2011 Nov; 254(5):809-16; discussion 816-7. PubMed ID: 22005152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.
    Folgueira MA; Carraro DM; Brentani H; Patrão DF; Barbosa EM; Netto MM; Caldeira JR; Katayama ML; Soares FA; Oliveira CT; Reis LF; Kaiano JH; Camargo LP; Vêncio RZ; Snitcovsky IM; Makdissi FB; e Silva PJ; Góes JC; Brentani MM
    Clin Cancer Res; 2005 Oct; 11(20):7434-43. PubMed ID: 16243817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy.
    Chen YZ; Xue JY; Chen CM; Yang BL; Xu QH; Wu F; Liu F; Ye X; Meng X; Liu GY; Shen ZZ; Shao ZM; Wu J
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):637-44. PubMed ID: 22903535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
    Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
    Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer.
    Rimkus C; Friederichs J; Boulesteix AL; Theisen J; Mages J; Becker K; Nekarda H; Rosenberg R; Janssen KP; Siewert JR
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):53-61. PubMed ID: 18166477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
    Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response.
    Langer R; Ott K; Specht K; Becker K; Lordick F; Burian M; Herrmann K; Schrattenholz A; Cahill MA; Schwaiger M; Hofler H; Wester HJ
    Clin Cancer Res; 2008 Dec; 14(24):8279-87. PubMed ID: 19088045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
    Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
    Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
    Schneider PM; Metzger R; Schaefer H; Baumgarten F; Vallbohmer D; Brabender J; Wolfgarten E; Bollschweiler E; Baldus SE; Dienes HP; Hoelscher AH
    Ann Surg; 2008 Dec; 248(6):902-8. PubMed ID: 19092334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128.
    Zempolich K; Fuhrman C; Milash B; Flinner R; Greven K; Ryu J; Forbes A; Kerlin K; Nichols RC; Gaffney DK
    Gynecol Oncol; 2008 May; 109(2):275-9. PubMed ID: 18299147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease.
    Modlich O; Prisack HB; Munnes M; Audretsch W; Bojar H
    Clin Cancer Res; 2004 Oct; 10(19):6418-31. PubMed ID: 15475428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray.
    Zhang X; Lin P; Zhu ZH; Long H; Wen J; Yang H; Zhang X; Wang DF; Fu JH; Fang Y; Rong TH
    Cancer Genet Cytogenet; 2009 Oct; 194(1):23-9. PubMed ID: 19737650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.